Spire Healthcare, one of the United Kingdom’s leading private healthcare providers, is actively weighing up a potential sale. The company, currently listed on the FTSE 250, faces mounting discontent from
All posts tagged in healthcare industry
12Articles
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Sir Pascal Soriot, the chief executive of AstraZeneca, Britain’s most valuable public company, has privately expressed his desire to relocate the pharmaceutical giant’s stock market listing to the United States,
Pascal Soriot, AstraZeneca’s chief executive, made waves at this year’s Boao Forum in China by boldly declaring the nation’s position as a key innovator in the pharmaceutical industry. His stance,
British ministers are actively engaging with pharmaceutical companies regarding potential US tariffs, prompting calls for an emergency taskforce to safeguard medicine supplies. The UK government is working diligently to maintain
The FTSE 100 medical equipment manufacturer Smith & Nephew faces intensifying shareholder pressure to consider a corporate break-up ahead of its annual results next week, particularly if its struggling orthopaedics
British pharmaceutical giant AstraZeneca has reported a significant 38% increase in pre-tax profits to £8.7 billion for 2024, driven by robust sales across its cancer, lung, and immunology treatments portfolio.
The recent decision by pharmaceutical giant AstraZeneca to abandon its £450 million investment plan in Liverpool has sparked serious concerns about Britain’s ability to attract and retain major corporate investments.
Danish pharmaceutical giant Novo Nordisk has projected reduced growth for 2025 amidst mounting competition in the weight-loss drugs market from American rivals. The company, renowned for its obesity treatments Ozempic
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv. The
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
AstraZeneca’s chief executive, Sir Pascal Soriot, has disclosed that former employees in China breached company protocols by using WeChat messaging services, amidst ongoing investigations by Chinese authorities. The revelation comes
